Bilal Mateen, MBBS, MPH, PhD
Bilal Mateen, MBBS, MPH, PhD, is the inaugural Chief AI Officer at PATH.
In this role, Dr. Mateen is responsible for developing and implementing PATH’s AI strategy while overseeing a number of programs focused on developing first-in-class AI-based solutions for addressing key health care challenges. This includes regulatory system strengthening to ensure adequate safeguards for this novel technology.
He most recently served as Executive Director of Digital Square where he supported ministries of health across Africa and Asia with effective planning, procurement, and implementation of technology to help address the global health equity gap. In this post, he served as principal investigator on more than $250 million in grants and contracts focused on digital health transformation in low-resource environments.
Dr. Mateen is a physician by training with an academic background in health-related applications of data science and machine learning. Prior to joining PATH, he served as the Clinical Technology Lead and Senior Manager for Digital Technology at the Wellcome Trust, one of the world’s largest philanthropic foundations supporting science and health research. Under his leadership, his team provided funding for digital public goods to address three key health challenges: mental health, the impact of climate change on human health, and emerging and escalating infectious diseases.
Dr. Mateen is deeply passionate about the role of research in advancing ethical and inclusive applications of artificial intelligence to improve human lives. Alongside his role at PATH, he continues to hold an honorary associate professorial appointment at University College London. He was also a fellow of the Alan Turing Institute, the UK’s national institute for data science and artificial intelligence.
Dr. Mateen completed his Bachelor of Science in Neuroscience and Medical Sciences and his medical training at University College London. He subsequently completed his Master of Public Health at the University of Edinburgh, and his PhD at King's College London.